INmune Bio Inc. (INMB)
NASDAQ: INMB
· Real-Time Price · USD
2.52
-0.01 (-0.40%)
At close: Aug 18, 2025, 3:59 PM
2.50
-1.12%
After-hours: Aug 18, 2025, 07:30 PM EDT
INmune Bio Revenue
INmune Bio reported an annual revenue of $14K, reflecting a -90.97% growth. For the quarter ending June 30, 2025, INmune Bio generated $0 in revenue.
Revenue (ttm)
14K
Revenue Growth
-90.97%
Price / Sales Ratio
6652.75
Revenue / Employee
1.08K
Employees
13
Market Cap
67.13M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 14K | -90.97% |
| Dec 31, 2023 | 155K | -58.56% |
| Dec 31, 2022 | 374K | +106.63% |
| Dec 31, 2021 | 181K | +1545.45% |
| Dec 31, 2020 | 11K | +Infinity% |
| Dec 31, 2019 | 0 | n/a |
| Dec 31, 2018 | 0 | n/a |
| Dec 31, 2017 | 0 | n/a |
| Dec 31, 2016 | 0 | n/a |
| Dec 31, 2015 | 0 | n/a |